您的位置: 首页 > 2016年5月 第47卷 第3期 > 文字全文
2023年7月 第38卷 第7期11
目录

PF诱导化疗联合调强放疗及二维放疗对鼻咽癌近远期疗效影响的回顾性分析

Retrospective analysis of the effects of PF induced chemotherapy combined with intensity modulated radiation therapy and two-dimensional radiotherapy on the short and long term curative effects in nasopharyngeal carcinoma

来源期刊: 广州医药 | 31-32 发布时间:2021-11-30 收稿时间:2025/11/13 17:00:33 阅读量:42
作者:
关键词:
PF诱导化疗调强放疗二维放疗鼻咽癌
PF induced chemotherapyIntensity modulated radiation therapyTwo-dimensional radiotherapyNasopharyngeal carcinoma
DOI:
10.3969/j.issn.1000-8535.2016.03.011
收稿时间:
2016-01-28 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 研究PF诱导化疗联合调强放疗及二维放疗对鼻咽癌近远期疗效影响的回顾性分析。方法 回顾性分析2008年1月—2008年12月中山大学附属肿瘤医院收治的101例鼻咽癌患者治疗情况,按照治疗方案技术分为调强组(n=42)和二维组(n=59)。比较两组患者临床疗效,近期毒副反应及生存情况。结果 放疗结束时调强组患者总缓解率92.86%与二维组77.97%比较差异有统计学意义(P<0.05)。调强组Ⅲ-Ⅳ级胃肠道反应26.19%及黏膜炎14.29%发生率与二维组比较显著较少,差异有统计学意义(P<0.05)。两组患者远期毒副反应及生存率比较无显著差异(P>0.05)。结论 PF诱导化疗联合调强放疗治疗鼻咽癌患者,近远期临床疗效好,毒副反应少。
Objective To study the effects of PF induced chemotherapy combined with intensity modulated radiation therapy and two-dimensional radiotherapy on the short and long term curative effects in nasopharyngeal carcinoma. Methods The treatment condition of 101 cases of patients with nasopharyngeal carcinoma who were treated in the Tumor Hospital Affiliated to San Yat-sen University between January and December 2008 were retrospectively analyzed. According to different treatments, the cases were divided into the intensity modulated group and the two-dimensional group. The clinical curative effects, short-term toxic and side effects and survival status were compared between the two groups. Results At the end of radiotherapy, the total remission rate in the intensity modulated group was 92.86% while in the two-dimensional group was 77.97% (P<0.05). In the intensity modulated group, the incidence rates of grade Ⅲ-Ⅳgastrointestinal tract reactions (26.19%) and mucositis (14.29%) were significantly lower than those in the two-dimensional group (P<0.05). There was no significant difference in long-term side effects and survival rate between the two groups (P>0.05). Conclusion PF induced chemotherapy combined with intensity modulated radiation therapy in the treatment of patients with nasopharyngeal carcinoma has good short and long-term curative effects and few toxic and side effects.
1、 梁毅,林少俊,潘建基,等.133例Ⅲ期鼻咽癌调强放疗的疗效及不良反应分析[J].中国癌症杂志,2012,22(3):212-217. 梁毅,林少俊,潘建基,等.133例Ⅲ期鼻咽癌调强放疗的疗效及不良反应分析[J].中国癌症杂志,2012,22(3):212-217.
2、 邵剑锋,李曙平,练英妮,等.尼妥珠单抗联合奈达铂同期放化疗治疗局部晚期鼻咽癌临床研究[J].中国现代医药杂志,2014,16(4):23-26. 邵剑锋,李曙平,练英妮,等.尼妥珠单抗联合奈达铂同期放化疗治疗局部晚期鼻咽癌临床研究[J].中国现代医药杂志,2014,16(4):23-26.
3、 易俊林,高黎,黄晓东,等.416例鼻咽癌调强放疗远期生存与影响因素分析[J].中华放射肿瘤学杂志,2012,21(3):196-200. 易俊林,高黎,黄晓东,等.416例鼻咽癌调强放疗远期生存与影响因素分析[J].中华放射肿瘤学杂志,2012,21(3):196-200.
4、 柳玉花,闫爱华,赵泉,等.鼻咽癌后程三维适形放疗与常规分割放疗的临床研究[J].中国现代医药杂志,2012,14(10):28-30. 柳玉花,闫爱华,赵泉,等.鼻咽癌后程三维适形放疗与常规分割放疗的临床研究[J].中国现代医药杂志,2012,14(10):28-30.
5、 雷风,陆小军,李民英,等.吉西他滨联合奈达铂诱导化疗后放疗治疗中晚期鼻咽癌临床观察[J].中国现代医药杂志,2013,15(11):20-22. 雷风,陆小军,李民英,等.吉西他滨联合奈达铂诱导化疗后放疗治疗中晚期鼻咽癌临床观察[J].中国现代医药杂志,2013,15(11):20-22.
6、 丘文泽,黄培钰,施君理,等.调强放疗结合诱导化疗或同期加辅助化疗治疗局部晚期鼻咽癌的疗效比较[J].中国肿瘤临床,2015,42(4):231-235. 丘文泽,黄培钰,施君理,等.调强放疗结合诱导化疗或同期加辅助化疗治疗局部晚期鼻咽癌的疗效比较[J].中国肿瘤临床,2015,42(4):231-235.
7、 陈映辉,丁文华,万华,等.82例鼻咽癌患者的首发症状与诊断分析[J].中国现代医学杂志,2015,25(4):107-109. 陈映辉,丁文华,万华,等.82例鼻咽癌患者的首发症状与诊断分析[J].中国现代医学杂志,2015,25(4):107-109.
8、 肖光莉,丘熹彬,王卫华,等.鼻咽癌调强放疗长期疗效及预后分析[J].中华放射肿瘤学杂志,2012,21(6):488-491. 肖光莉,丘熹彬,王卫华,等.鼻咽癌调强放疗长期疗效及预后分析[J].中华放射肿瘤学杂志,2012,21(6):488-491.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录